Stay updated on CNTO1959 for Pustular/Erythrodermic Psoriasis Clinical Trial
Sign up to get notified when there's something new on the CNTO1959 for Pustular/Erythrodermic Psoriasis Clinical Trial page.

Latest updates to the CNTO1959 for Pustular/Erythrodermic Psoriasis Clinical Trial page
- CheckyesterdayChange DetectedRevision updated to v3.0.2 and the Back to Top element was removed. No core content, pricing, stock, or time-slot information was affected.SummaryDifference0.2%
- Check9 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check16 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as the introduction of new content related to guselkumab and skin and connective tissue diseases. The revision number has also been updated to v3.0.0.SummaryDifference1%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check44 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.8%
Stay in the know with updates to CNTO1959 for Pustular/Erythrodermic Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CNTO1959 for Pustular/Erythrodermic Psoriasis Clinical Trial page.